Astellas Pharma Inc. announced that the Science Based Targets initiative has validated and approved its greenhouse gas emissions reduction targets. The targets, as a science-based initiative, have been approved towards achieving the 1.5 degrees Celsius and well-below 2 degrees Celsius targets of the Paris Climate Agreement. Astellas has set "Deepen engagement in sustainability" as one of the strategic goals in its Corporate Strategic Plan 2021.

The reduction of environmental burden is Astellas' priority themes within sustainability. Astellas' revised targets are as follows: Astellas commits to reduce absolute scope 1 and 2 GHG emissions by 63% by FY2030 from the FY2015 base year. <1.5 degrees Celsius target.

Astellas also commits to reduce absolute scope 3 GHG emissions by 37.5% by FY2030 from the FY2015 base year.